These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6120500)

  • 41. [Stimulation of alpha adrenergic receptors by isoproterenol].
    Zhang PW
    Sheng Li Ke Xue Jin Zhan; 1984 Apr; 15(2):175-7. PubMed ID: 6093245
    [No Abstract]   [Full Text] [Related]  

  • 42. Correlation between the inhibitory activities of calcium entry blockers on vascular smooth muscle constriction in vitro after K+-depolarisation and in vivo after alpha 2-adrenoceptor stimulation.
    van Meel JC; Towart R; Kazda S; Timmermans PB; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):34-7. PubMed ID: 6302522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of calcium blockers on the morphofunctional state of the capillary system of the cerebral cortex].
    Gabrielian ES; Matevosian RSh
    Biull Eksp Biol Med; 1984 Sep; 98(9):310-2. PubMed ID: 6091809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor subtypes involved in the action of calcium entry blockers.
    van Zwieten PA; Timmermans PB
    Ann N Y Acad Sci; 1988; 522():351-60. PubMed ID: 2454059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive and arterial anticalcinotic effects of calcium antagonists.
    Fleckenstein A; Frey M; Fleckenstein-Grün G
    Am J Cardiol; 1986 Feb; 57(7):1D-10D. PubMed ID: 3513510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship of receptor reserve and agonist efficacy to the sensitivity of alpha-adrenoceptor-mediated vasopressor responses to inhibition by calcium channel antagonists.
    Ruffolo RR; Nichols AJ
    Ann N Y Acad Sci; 1988; 522():361-76. PubMed ID: 2897818
    [No Abstract]   [Full Text] [Related]  

  • 47. Vasodilator drugs: systemic and regional considerations.
    Brown MJ
    Anaesth Intensive Care; 1980 Aug; 8(3):310-7. PubMed ID: 6999938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium antagonism and vascular smooth muscle.
    van Nueten JM; Janssens WJ; Vanhoutte PM
    Ann N Y Acad Sci; 1988; 522():234-47. PubMed ID: 2837122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular effects of calcium antagonists. Uses in some cerebrovascular disorders.
    Marin J
    Gen Pharmacol; 1988; 19(3):295-306. PubMed ID: 2458295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
    [No Abstract]   [Full Text] [Related]  

  • 51. Calcium-entry blockers, vascular smooth muscle and systemic hypertension.
    Vanhoutte PM
    Am J Cardiol; 1985 Jan; 55(3):17B-23B. PubMed ID: 3881910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [From calcium antagonists to calcium antagonism].
    Ferrari R; Visioli O
    Cardiologia; 1985 Jan; 30(1):15-20. PubMed ID: 3896491
    [No Abstract]   [Full Text] [Related]  

  • 53. Calcium antagonists as vasodilators.
    Thulesius O
    Vasa; 1986; 15(2):111-4. PubMed ID: 2425506
    [No Abstract]   [Full Text] [Related]  

  • 54. Differentiation of calcium entry blockers into calcium channel blockers and calcium overload blockers.
    van Zwieten PA
    Eur Neurol; 1986; 25 Suppl 1():57-67. PubMed ID: 3758108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart.
    Hof RP; Salzmann R; Siegl H
    Am J Cardiol; 1987 Jan; 59(3):30B-36B. PubMed ID: 2949586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcium antagonists, cerebral ischemia and vasospasm.
    Weir B
    Can J Neurol Sci; 1984 May; 11(2):239-46. PubMed ID: 6375843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of methylhesperidin on coronary, renal and cerebral circulation in dogs].
    Feng MG; Feng GH; Zhou QG
    Zhongguo Yao Li Xue Bao; 1988 Nov; 9(6):548-50. PubMed ID: 3256219
    [No Abstract]   [Full Text] [Related]  

  • 58. Distribution and function of peripheral alpha-adrenoceptors in the cardiovascular system.
    Ruffolo RR
    Pharmacol Biochem Behav; 1985 May; 22(5):827-33. PubMed ID: 2989947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular effects of calcium antagonists: implications for hypertension and other risk factors for coronary heart disease.
    van Zwieten PA
    Am J Cardiol; 1989 Nov; 64(17):117I-121I. PubMed ID: 2554709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional consequences of contrasting properties of alpha 1/alpha 2 systems.
    Timmermans PB; Thoolen MJ; De Jonge A; Wilffert B; Van Zwieten PA
    Clin Sci (Lond); 1985; 68 Suppl 10():93s-97s. PubMed ID: 2857626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.